FDA drug promotion rules spotlight compounded meds in Hims & Hers Super Bowl ad controversy
This article unpacks the regulatory framework implicated by the Hims & Hers’ Super Bowl advertisement, explores the implications for the company and the broader pharmaceutical and telehealth industries, and discusses how evolving enforcement trends may shape future drug promotion practices.